Daniel Voth
Concepts (357)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coxiella burnetii | 34 | 2025 | 34 | 11.760 |
Why?
| | Q Fever | 17 | 2025 | 18 | 6.630 |
Why?
| | Host-Pathogen Interactions | 19 | 2025 | 135 | 6.270 |
Why?
| | Macrophages, Alveolar | 11 | 2025 | 27 | 5.060 |
Why?
| | Bacterial Secretion Systems | 11 | 2020 | 12 | 2.940 |
Why?
| | Bacterial Proteins | 18 | 2025 | 347 | 2.680 |
Why?
| | Macrophages | 18 | 2026 | 380 | 2.640 |
Why?
| | Bacterial Toxins | 10 | 2019 | 52 | 1.790 |
Why?
| | Lung | 5 | 2024 | 481 | 1.730 |
Why?
| | Cytoplasm | 4 | 2019 | 93 | 1.620 |
Why?
| | Virulence Factors | 4 | 2019 | 79 | 1.560 |
Why?
| | Vacuoles | 10 | 2025 | 22 | 1.220 |
Why?
| | Phagosomes | 4 | 2019 | 16 | 1.210 |
Why?
| | Models, Biological | 4 | 2021 | 737 | 1.070 |
Why?
| | Bacteria | 3 | 2022 | 226 | 1.010 |
Why?
| | Autophagy | 4 | 2016 | 199 | 0.970 |
Why?
| | Signal Transduction | 10 | 2025 | 1748 | 0.940 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 3 | 2016 | 50 | 0.880 |
Why?
| | Bacterial Infections | 2 | 2022 | 96 | 0.820 |
Why?
| | Plasmids | 3 | 2015 | 164 | 0.820 |
Why?
| | Anti-Bacterial Agents | 5 | 2026 | 830 | 0.770 |
Why?
| | Disease Models, Animal | 3 | 2024 | 1517 | 0.730 |
Why?
| | Protein Transport | 8 | 2020 | 168 | 0.700 |
Why?
| | Neurotransmitter Agents | 1 | 2021 | 32 | 0.700 |
Why?
| | Mitochondria | 1 | 2025 | 446 | 0.690 |
Why?
| | Humans | 60 | 2025 | 53230 | 0.680 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 66 | 0.670 |
Why?
| | Pharmaceutical Preparations | 1 | 2021 | 74 | 0.670 |
Why?
| | Apoptosis | 5 | 2012 | 1139 | 0.660 |
Why?
| | Carrier Proteins | 2 | 2015 | 315 | 0.650 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2020 | 18 | 0.650 |
Why?
| | Lung Diseases | 1 | 2021 | 84 | 0.650 |
Why?
| | Staphylococcus aureus | 2 | 2021 | 313 | 0.630 |
Why?
| | Leukocidins | 1 | 2019 | 6 | 0.610 |
Why?
| | Exotoxins | 1 | 2019 | 8 | 0.610 |
Why?
| | Eukaryotic Cells | 2 | 2016 | 15 | 0.600 |
Why?
| | Cell Line | 13 | 2016 | 1016 | 0.590 |
Why?
| | Phosphoproteins | 2 | 2016 | 117 | 0.570 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 47 | 0.550 |
Why?
| | Animals | 27 | 2026 | 13526 | 0.520 |
Why?
| | HeLa Cells | 9 | 2019 | 243 | 0.510 |
Why?
| | Gram-Negative Bacteria | 2 | 2019 | 34 | 0.500 |
Why?
| | Actin Cytoskeleton | 1 | 2016 | 22 | 0.500 |
Why?
| | Microfilament Proteins | 1 | 2016 | 44 | 0.500 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 271 | 0.490 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 88 | 0.490 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 44 | 0.490 |
Why?
| | Lysosomes | 3 | 2016 | 68 | 0.490 |
Why?
| | Antigens, Bacterial | 5 | 2006 | 55 | 0.450 |
Why?
| | Cells, Cultured | 6 | 2025 | 1569 | 0.440 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 99 | 0.420 |
Why?
| | Legionella pneumophila | 4 | 2021 | 5 | 0.420 |
Why?
| | Recombinant Proteins | 1 | 2015 | 489 | 0.400 |
Why?
| | Gene Expression Regulation, Bacterial | 3 | 2012 | 177 | 0.400 |
Why?
| | Meningomyelocele | 6 | 2001 | 27 | 0.380 |
Why?
| | Mice | 14 | 2026 | 5982 | 0.370 |
Why?
| | Virulence | 6 | 2025 | 163 | 0.330 |
Why?
| | Ankyrin Repeat | 1 | 2009 | 4 | 0.300 |
Why?
| | Cyclic AMP | 2 | 2009 | 91 | 0.300 |
Why?
| | Embryo, Nonmammalian | 2 | 2006 | 21 | 0.290 |
Why?
| | Biological Transport | 1 | 2009 | 150 | 0.290 |
Why?
| | Oncogene Protein v-akt | 1 | 2008 | 12 | 0.290 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 46 | 0.290 |
Why?
| | Membrane Transport Proteins | 1 | 2009 | 46 | 0.290 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 47 | 0.290 |
Why?
| | Molecular Chaperones | 1 | 2009 | 76 | 0.290 |
Why?
| | Gram-Negative Bacterial Infections | 3 | 2019 | 45 | 0.260 |
Why?
| | Membrane Proteins | 1 | 2009 | 333 | 0.250 |
Why?
| | Clostridium sordellii | 1 | 2006 | 1 | 0.250 |
Why?
| | Cytotoxins | 1 | 2006 | 15 | 0.250 |
Why?
| | DNA, Bacterial | 4 | 2012 | 167 | 0.250 |
Why?
| | Click Chemistry | 1 | 2026 | 4 | 0.240 |
Why?
| | Rifamycins | 1 | 2026 | 6 | 0.240 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2026 | 64 | 0.240 |
Why?
| | Leishmania major | 1 | 2026 | 12 | 0.240 |
Why?
| | Bacterial Vaccines | 1 | 2025 | 9 | 0.240 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2026 | 15 | 0.240 |
Why?
| | Arginase | 1 | 2026 | 40 | 0.240 |
Why?
| | Myeloid Cells | 1 | 2026 | 45 | 0.240 |
Why?
| | Phosphorylation | 4 | 2016 | 533 | 0.240 |
Why?
| | GTP-Binding Proteins | 1 | 2026 | 85 | 0.240 |
Why?
| | Guinea Pigs | 2 | 2024 | 75 | 0.230 |
Why?
| | Genome, Bacterial | 3 | 2018 | 60 | 0.230 |
Why?
| | Enterotoxins | 1 | 2005 | 12 | 0.230 |
Why?
| | Oxidative Phosphorylation | 1 | 2025 | 48 | 0.230 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2005 | 24 | 0.220 |
Why?
| | Bacillus anthracis | 4 | 2006 | 14 | 0.220 |
Why?
| | Borrelia | 1 | 2024 | 3 | 0.220 |
Why?
| | Relapsing Fever | 1 | 2024 | 3 | 0.220 |
Why?
| | Clostridium | 1 | 2004 | 16 | 0.210 |
Why?
| | Immunoblotting | 3 | 2016 | 118 | 0.210 |
Why?
| | Mice, SCID | 1 | 2024 | 180 | 0.210 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2018 | 169 | 0.210 |
Why?
| | Vaccination | 1 | 2025 | 310 | 0.200 |
Why?
| | Enzyme Activation | 2 | 2016 | 267 | 0.190 |
Why?
| | Scoliosis | 2 | 1993 | 63 | 0.180 |
Why?
| | Pharmacology | 1 | 2021 | 5 | 0.180 |
Why?
| | Microtomy | 1 | 2021 | 2 | 0.170 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 39 | 0.170 |
Why?
| | Tissue Banks | 1 | 2021 | 9 | 0.170 |
Why?
| | Tissue Culture Techniques | 1 | 2021 | 42 | 0.170 |
Why?
| | Inflammation | 1 | 2025 | 652 | 0.170 |
Why?
| | Kyphosis | 2 | 1999 | 17 | 0.170 |
Why?
| | Primary Cell Culture | 1 | 2021 | 62 | 0.170 |
Why?
| | Monocytes | 2 | 2015 | 126 | 0.170 |
Why?
| | Mutation | 6 | 2016 | 1337 | 0.170 |
Why?
| | Cell Survival | 2 | 2013 | 600 | 0.170 |
Why?
| | Neurosurgery | 2 | 1999 | 36 | 0.170 |
Why?
| | Yersinia pestis | 1 | 2021 | 21 | 0.170 |
Why?
| | Arachnoid Cysts | 2 | 1998 | 5 | 0.170 |
Why?
| | Transcription Factor CHOP | 1 | 2020 | 7 | 0.160 |
Why?
| | Activating Transcription Factor 6 | 1 | 2020 | 16 | 0.160 |
Why?
| | Intervertebral Disc Displacement | 2 | 1992 | 13 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 171 | 0.150 |
Why?
| | Mycobacterium tuberculosis | 1 | 2021 | 250 | 0.150 |
Why?
| | Phylogeny | 2 | 2018 | 231 | 0.150 |
Why?
| | Base Sequence | 3 | 2011 | 620 | 0.150 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2019 | 11 | 0.150 |
Why?
| | Desipramine | 1 | 2019 | 26 | 0.150 |
Why?
| | Species Specificity | 2 | 2012 | 191 | 0.150 |
Why?
| | Acids | 1 | 2018 | 9 | 0.150 |
Why?
| | MicroRNAs | 1 | 2022 | 397 | 0.140 |
Why?
| | MAP Kinase Signaling System | 4 | 2013 | 127 | 0.140 |
Why?
| | Biological Assay | 2 | 2016 | 46 | 0.140 |
Why?
| | Histones | 1 | 2020 | 318 | 0.140 |
Why?
| | Orthopedics | 1 | 1999 | 54 | 0.140 |
Why?
| | Cricetinae | 3 | 2006 | 190 | 0.130 |
Why?
| | Caspases | 2 | 2007 | 101 | 0.130 |
Why?
| | Zebrafish | 3 | 2006 | 61 | 0.130 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 32 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 371 | 0.130 |
Why?
| | Mice, Inbred C57BL | 4 | 2026 | 1925 | 0.130 |
Why?
| | Immunoprecipitation | 1 | 2016 | 56 | 0.130 |
Why?
| | rab GTP-Binding Proteins | 1 | 2016 | 23 | 0.130 |
Why?
| | Chloramphenicol | 2 | 2016 | 4 | 0.130 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 75 | 0.120 |
Why?
| | Microtubules | 1 | 2016 | 35 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 109 | 0.120 |
Why?
| | Vesicular Transport Proteins | 1 | 2016 | 33 | 0.120 |
Why?
| | Child, Preschool | 13 | 2001 | 4162 | 0.120 |
Why?
| | Seizures | 1 | 1998 | 203 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2007 | 21 | 0.120 |
Why?
| | Microbial Viability | 1 | 2015 | 31 | 0.120 |
Why?
| | Gene Expression | 3 | 2015 | 618 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 1998 | 1180 | 0.120 |
Why?
| | Protein Sorting Signals | 1 | 2015 | 7 | 0.110 |
Why?
| | Mice, Inbred BALB C | 2 | 2006 | 310 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2016 | 180 | 0.110 |
Why?
| | NF-kappa B | 1 | 2016 | 327 | 0.110 |
Why?
| | Open Reading Frames | 1 | 2015 | 52 | 0.110 |
Why?
| | Transgenes | 1 | 2015 | 55 | 0.110 |
Why?
| | Computer Simulation | 2 | 2016 | 290 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 71 | 0.110 |
Why?
| | Postoperative Complications | 6 | 1993 | 1099 | 0.110 |
Why?
| | Lumbar Vertebrae | 2 | 1993 | 101 | 0.110 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 252 | 0.110 |
Why?
| | HEK293 Cells | 1 | 2015 | 235 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1994 | 235 | 0.110 |
Why?
| | Bone Resorption | 1 | 2016 | 304 | 0.110 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 563 | 0.100 |
Why?
| | Cytosol | 2 | 2014 | 80 | 0.100 |
Why?
| | Osteoclasts | 1 | 2016 | 428 | 0.100 |
Why?
| | Gammaherpesvirinae | 1 | 2013 | 21 | 0.100 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 759 | 0.100 |
Why?
| | Female | 16 | 2026 | 28782 | 0.100 |
Why?
| | Substrate Specificity | 1 | 2013 | 197 | 0.100 |
Why?
| | Adolescent | 12 | 2001 | 6907 | 0.100 |
Why?
| | Child | 14 | 2001 | 7379 | 0.090 |
Why?
| | Infant | 10 | 2001 | 3805 | 0.090 |
Why?
| | Virus Replication | 1 | 2013 | 149 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 88 | 0.090 |
Why?
| | Dihydroergotamine | 1 | 1992 | 5 | 0.090 |
Why?
| | Frontal Bone | 1 | 1992 | 2 | 0.090 |
Why?
| | Viral Proteins | 1 | 2013 | 164 | 0.090 |
Why?
| | Anaplasma marginale | 1 | 2011 | 1 | 0.090 |
Why?
| | Thrombophlebitis | 1 | 1992 | 19 | 0.090 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 1992 | 22 | 0.090 |
Why?
| | Spinal Fusion | 1 | 1993 | 73 | 0.090 |
Why?
| | Bone Plates | 1 | 1992 | 17 | 0.090 |
Why?
| | Orbit | 1 | 1992 | 26 | 0.090 |
Why?
| | Titanium | 1 | 1992 | 36 | 0.090 |
Why?
| | Ubiquitination | 1 | 2012 | 58 | 0.090 |
Why?
| | Craniotomy | 1 | 1992 | 31 | 0.090 |
Why?
| | Interleukin-6 | 1 | 2013 | 272 | 0.090 |
Why?
| | Craniosynostoses | 1 | 1992 | 39 | 0.090 |
Why?
| | Heparin | 1 | 1992 | 86 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 392 | 0.080 |
Why?
| | Caspase Inhibitors | 2 | 2007 | 16 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2012 | 374 | 0.080 |
Why?
| | Mice, Knockout | 2 | 2026 | 910 | 0.080 |
Why?
| | Genes, Bacterial | 2 | 2006 | 51 | 0.080 |
Why?
| | Receptors, Peptide | 2 | 2006 | 9 | 0.080 |
Why?
| | Cysts | 2 | 1989 | 53 | 0.070 |
Why?
| | Arachnoid | 1 | 1989 | 1 | 0.070 |
Why?
| | Brain Neoplasms | 1 | 1993 | 319 | 0.070 |
Why?
| | CHO Cells | 2 | 2006 | 124 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 140 | 0.070 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 1989 | 33 | 0.070 |
Why?
| | DNA Transposable Elements | 1 | 2008 | 107 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 1470 | 0.070 |
Why?
| | Male | 15 | 2019 | 27435 | 0.070 |
Why?
| | Glucosyltransferases | 1 | 2007 | 6 | 0.070 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 13 | 0.070 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2007 | 30 | 0.070 |
Why?
| | Staurosporine | 1 | 2007 | 10 | 0.070 |
Why?
| | Genetic Variation | 1 | 2008 | 223 | 0.070 |
Why?
| | Vero Cells | 1 | 2007 | 40 | 0.070 |
Why?
| | bcl-X Protein | 1 | 2007 | 56 | 0.060 |
Why?
| | Intervertebral Disc Chemolysis | 1 | 1987 | 1 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2007 | 90 | 0.060 |
Why?
| | Lethal Dose 50 | 1 | 2006 | 11 | 0.060 |
Why?
| | NIH 3T3 Cells | 1 | 2006 | 52 | 0.060 |
Why?
| | Follow-Up Studies | 6 | 1998 | 2318 | 0.060 |
Why?
| | Streptococcus mutans | 1 | 2026 | 1 | 0.060 |
Why?
| | Containment of Biohazards | 1 | 2025 | 1 | 0.060 |
Why?
| | Air Sacs | 1 | 2005 | 1 | 0.060 |
Why?
| | Interleukin-17 | 1 | 2025 | 34 | 0.060 |
Why?
| | History, 21st Century | 1 | 2025 | 60 | 0.060 |
Why?
| | Cholesterol | 1 | 2006 | 161 | 0.060 |
Why?
| | History, 20th Century | 1 | 2025 | 97 | 0.060 |
Why?
| | Swiss 3T3 Cells | 1 | 2005 | 2 | 0.060 |
Why?
| | Cricetulus | 1 | 2005 | 101 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2026 | 174 | 0.060 |
Why?
| | Skull | 1 | 2005 | 75 | 0.060 |
Why?
| | Molecular Structure | 1 | 2026 | 320 | 0.060 |
Why?
| | Adult | 10 | 2001 | 14534 | 0.060 |
Why?
| | Necrosis | 1 | 2005 | 169 | 0.060 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2026 | 83 | 0.060 |
Why?
| | Microbial Sensitivity Tests | 1 | 2026 | 274 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2026 | 396 | 0.060 |
Why?
| | Genotype | 1 | 2006 | 563 | 0.050 |
Why?
| | Gene Deletion | 2 | 2016 | 279 | 0.050 |
Why?
| | Genetic Complementation Test | 1 | 2024 | 42 | 0.050 |
Why?
| | Glycosyltransferases | 1 | 2004 | 7 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2025 | 203 | 0.050 |
Why?
| | Gastrointestinal Tract | 1 | 2005 | 110 | 0.050 |
Why?
| | Dimerization | 1 | 2004 | 50 | 0.050 |
Why?
| | Molecular Weight | 1 | 2004 | 77 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2024 | 85 | 0.050 |
Why?
| | Endopeptidases | 1 | 2004 | 62 | 0.050 |
Why?
| | Heart | 1 | 2006 | 350 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2001 | 5595 | 0.050 |
Why?
| | Phenotype | 1 | 2006 | 803 | 0.050 |
Why?
| | Cytokines | 1 | 2025 | 627 | 0.050 |
Why?
| | Endosomes | 2 | 2016 | 35 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 35 | 0.050 |
Why?
| | Time Factors | 1 | 2008 | 2991 | 0.050 |
Why?
| | Dura Mater | 1 | 2001 | 12 | 0.040 |
Why?
| | Masseter Muscle | 1 | 2001 | 1 | 0.040 |
Why?
| | Blinking | 1 | 2001 | 4 | 0.040 |
Why?
| | Central Nervous System Diseases | 1 | 2001 | 28 | 0.040 |
Why?
| | Pericardium | 1 | 2001 | 32 | 0.040 |
Why?
| | Bioprosthesis | 1 | 2001 | 41 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 3 | 1999 | 1583 | 0.040 |
Why?
| | Arnold-Chiari Malformation | 1 | 2001 | 22 | 0.040 |
Why?
| | Liver | 1 | 2005 | 1150 | 0.040 |
Why?
| | Orthopedic Fixation Devices | 1 | 1999 | 4 | 0.040 |
Why?
| | Cholesterol, LDL | 1 | 2019 | 42 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 94 | 0.040 |
Why?
| | Proteome | 2 | 2013 | 177 | 0.040 |
Why?
| | Reoperation | 2 | 1999 | 476 | 0.040 |
Why?
| | Middle Aged | 7 | 2001 | 13419 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2016 | 1133 | 0.030 |
Why?
| | Neutrophils | 1 | 2019 | 153 | 0.030 |
Why?
| | NF-kappa B p52 Subunit | 1 | 2016 | 6 | 0.030 |
Why?
| | Cattle | 2 | 2011 | 207 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 13 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 289 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 1998 | 137 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2016 | 98 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 202 | 0.030 |
Why?
| | Homeostasis | 1 | 2016 | 209 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2016 | 218 | 0.030 |
Why?
| | Craniofacial Dysostosis | 1 | 1994 | 1 | 0.030 |
Why?
| | Facial Bones | 1 | 1994 | 18 | 0.030 |
Why?
| | Skull Fractures | 1 | 1994 | 17 | 0.030 |
Why?
| | Headache | 1 | 1995 | 75 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 175 | 0.030 |
Why?
| | Cyclin D | 1 | 2013 | 18 | 0.030 |
Why?
| | Cell Membrane | 1 | 2014 | 233 | 0.030 |
Why?
| | 3T3 Cells | 1 | 2013 | 57 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2016 | 681 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2013 | 76 | 0.030 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 57 | 0.020 |
Why?
| | Aged | 5 | 2001 | 10429 | 0.020 |
Why?
| | Cranial Fossa, Posterior | 1 | 1993 | 9 | 0.020 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 1993 | 25 | 0.020 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 1993 | 29 | 0.020 |
Why?
| | Thoracic Vertebrae | 1 | 1993 | 38 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 333 | 0.020 |
Why?
| | Spine | 1 | 1993 | 87 | 0.020 |
Why?
| | Epilepsy | 1 | 1995 | 189 | 0.020 |
Why?
| | Adenylate Cyclase Toxin | 1 | 2011 | 1 | 0.020 |
Why?
| | Gene Order | 1 | 2011 | 13 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 254 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 209 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 1993 | 114 | 0.020 |
Why?
| | Drug Combinations | 1 | 1992 | 138 | 0.020 |
Why?
| | Proteomics | 1 | 2013 | 336 | 0.020 |
Why?
| | Hemorrhage | 1 | 1992 | 226 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1992 | 729 | 0.020 |
Why?
| | Uveomeningoencephalitic Syndrome | 1 | 1989 | 1 | 0.020 |
Why?
| | Age Factors | 1 | 1993 | 1136 | 0.020 |
Why?
| | Uveitis | 1 | 1989 | 24 | 0.020 |
Why?
| | Chromosomes, Bacterial | 1 | 2008 | 5 | 0.020 |
Why?
| | Hypothyroidism | 1 | 1989 | 58 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 119 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 145 | 0.020 |
Why?
| | Neural Tube Defects | 1 | 1988 | 33 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2011 | 1219 | 0.020 |
Why?
| | Cerebral Hemorrhage | 1 | 1989 | 102 | 0.020 |
Why?
| | Prognosis | 1 | 1993 | 2118 | 0.020 |
Why?
| | Comet Assay | 1 | 2006 | 11 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2006 | 9 | 0.020 |
Why?
| | Genomics | 1 | 2008 | 271 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 48 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2006 | 68 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1989 | 224 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2006 | 26 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2006 | 44 | 0.020 |
Why?
| | Spinal Cord Diseases | 1 | 1987 | 39 | 0.020 |
Why?
| | Risk Factors | 2 | 1993 | 4017 | 0.020 |
Why?
| | Retrospective Studies | 3 | 2001 | 6819 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2006 | 90 | 0.020 |
Why?
| | Prospective Studies | 1 | 1992 | 2411 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2006 | 294 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2006 | 147 | 0.010 |
Why?
| | Heart Rate | 1 | 2006 | 314 | 0.010 |
Why?
| | Molecular Motor Proteins | 1 | 2003 | 8 | 0.010 |
Why?
| | Multienzyme Complexes | 1 | 2003 | 42 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2003 | 64 | 0.010 |
Why?
| | Tubulin | 1 | 2003 | 22 | 0.010 |
Why?
| | Drug Resistance | 1 | 2003 | 71 | 0.010 |
Why?
| | Ubiquitin | 1 | 2003 | 70 | 0.010 |
Why?
| | Cell Death | 1 | 2003 | 171 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2003 | 141 | 0.010 |
Why?
| | Cell Cycle | 1 | 2003 | 237 | 0.010 |
Why?
| | Tissue Preservation | 1 | 2001 | 7 | 0.010 |
Why?
| | Medical Records | 1 | 2001 | 85 | 0.010 |
Why?
| | Electrodiagnosis | 1 | 2001 | 13 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2001 | 103 | 0.010 |
Why?
| | Rats | 1 | 2006 | 3162 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2001 | 291 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2001 | 867 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1994 | 101 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2001 | 3494 | 0.010 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 1993 | 29 | 0.010 |
Why?
| | Heart Atria | 1 | 1993 | 64 | 0.010 |
Why?
| | Hydrocephalus | 1 | 1993 | 46 | 0.010 |
Why?
| | Recurrence | 1 | 1993 | 694 | 0.010 |
Why?
| | Tissue Adhesions | 1 | 1988 | 37 | 0.000 |
Why?
| | Sensation | 1 | 1987 | 11 | 0.000 |
Why?
| | Lipoma | 1 | 1987 | 17 | 0.000 |
Why?
| | Movement Disorders | 1 | 1987 | 17 | 0.000 |
Why?
| | Spinal Cord Compression | 1 | 1987 | 13 | 0.000 |
Why?
| | Spinal Cord Neoplasms | 1 | 1987 | 14 | 0.000 |
Why?
| | Infant, Newborn | 1 | 1993 | 2913 | 0.000 |
Why?
|
|
Voth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|